- Home
- BIVI vs YOTA Comparison
BIVI vs YOTA Comparison
Compare BIVI & YOTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- YOTA
- Stock Information
- Founded
- BIVI 2013
- YOTA 2021
- Country
- BIVI United States
- YOTA United States
- Employees
- BIVI N/A
- YOTA N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- YOTA Farming/Seeds/Milling
- Sector
- BIVI Health Care
- YOTA Consumer Staples
- Exchange
- BIVI Nasdaq
- YOTA Nasdaq
- Market Cap
- BIVI 45.1M
- YOTA 43.9M
- IPO Year
- BIVI N/A
- YOTA 2022
- Fundamental
- Price
- BIVI $3.11
- YOTA $11.25
- Analyst Decision
- BIVI Strong Buy
- YOTA
- Analyst Count
- BIVI 2
- YOTA 0
- Target Price
- BIVI $40.00
- YOTA N/A
- AVG Volume (30 Days)
- BIVI 3.3M
- YOTA 1.3K
- Earning Date
- BIVI 11-13-2024
- YOTA 01-01-0001
- Dividend Yield
- BIVI N/A
- YOTA N/A
- EPS Growth
- BIVI N/A
- YOTA 35.55
- EPS
- BIVI N/A
- YOTA 0.13
- Revenue
- BIVI N/A
- YOTA N/A
- Revenue This Year
- BIVI N/A
- YOTA N/A
- Revenue Next Year
- BIVI N/A
- YOTA N/A
- P/E Ratio
- BIVI N/A
- YOTA $85.06
- Revenue Growth
- BIVI N/A
- YOTA N/A
- 52 Week Low
- BIVI $1.04
- YOTA $10.35
- 52 Week High
- BIVI $56.54
- YOTA $15.49
- Technical
- Relative Strength Index (RSI)
- BIVI 56.34
- YOTA 72.10
- Support Level
- BIVI $2.87
- YOTA $11.17
- Resistance Level
- BIVI $3.85
- YOTA $11.23
- Average True Range (ATR)
- BIVI 0.39
- YOTA 0.03
- MACD
- BIVI 0.01
- YOTA 0.01
- Stochastic Oscillator
- BIVI 51.32
- YOTA 100.00
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About YOTA Yotta Acquisition Corporation
Yotta Acquisition Corp is a shell company.